微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 6.8% | -24.11% | 53.5% | 43/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.43% | -21.31% | 83.06% | 39/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.42% | -6.2% | -74.5% | 43/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 9.49% | -1.15% | 5.92% | 31/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 8.96% | 5.29% | 59.15% | 33/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.63% | 5.23% | 118.22% | 31/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.58% | 7.05% | -73.13% | 47/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 9.6% | -19.46% | 12.81% | 33/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.51% | -19.64% | 59.07% | 33/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.35% | -14.94% | 121.99% | 38/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.41% | -7.66% | -79.78% | 51/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.92% | -1.57% | 12.56% | 32/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 10.59% | 5.48% | 68.36% | 28/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.29% | 5.18% | 141% | 32/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.61% | 6.1% | -78.45% | 46/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.11% | -14.05% | 20.62% | 32/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 10.04% | -13.97% | 67.89% | 32/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.98% | -8.56% | 143.09% | 38/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.46% | 8.85% | -82.54% | 54/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 14.09% | 3.45% | 20.74% | 33/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 11.67% | 9.37% | 78.44% | 27/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.54% | 7.57% | 189.38% | 39/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.26% | 3.67% | -83.41% | 47/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 13.62% | 20.64% | 27.65% | 35/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.67% | 22.5% | 75.49% | 31/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.08% | 25.88% | 178.9% | 38/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.18% | 27.49% | -80.69% | 54/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 11.29% | 38.53% | 29.62% | 43/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.71% | 39.81% | 80.33% | 33/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.83% | 37.61% | 182.46% | 43/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.71% | 134.25% | -79.02% | 63/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.15% | 35.83% | 30.82% | 63/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 6.23% | 33.4% | 77.49% | 52/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.51% | 29.04% | 380.82% | 68/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.73% | 15.87% | -87.83% | 69/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 6% | -10.98% | 28.48% | 75/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.67% | -21.25% | 71.69% | 51/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.72% | -18.81% | 331.75% | 58/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.63% | -34.38% | -90.65% | 66/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 6.74% | 58.22% | 13.66% | 65/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 5.93% | 69.43% | 77.01% | 42/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.35% | 39.58% | 248.96% | 51/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.96% | 39.13% | -77.46% | 52/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |